our Human Resources policy

RESOURCES

Circle Oncodesign Services

The process of discovery and development of a molecule is complex, long and costly. Before making a decision on the offer that best meets your needs, we offer online scientific resources and our latest news to help you get to know us better. Our experts are also at your disposal to help and support you in your research and development program.

Filter by category
  • All
  • Blog
  • Congress
  • Scientific resource
  • Webinar
  • Poster
  • Scientific publication
  • Press release
  • Press coverage
  • News
Filter by category
Circle Oncodesign Services
Scientific publication
29/02/2024

Gut Microbiome Integration in Drug Discovery and Development of Small Molecules

More than 30 international leading experts has developed proposals to facilitate integration of the microbiome in drug discovery and development.

ITW ODS x Zobio
News
22/02/2024

Oncodesign Services x ZoBio – ITW

Follow our exciting story and stay tuned to witness the positive impact this union can have on research!

ITW with Phinc and Oncodesign Services
News
22/02/2024

Phinc & Oncodesign Services

With Oncodesign Services and Phinc, unlocking the power of PBPK prediction and ADMET experimentation for a better drug development!

Poster scientifique | Oncodesign Services
Poster
05/02/2024

Advancing Drug Discovery through 3D Cell Models: Unveiling Novel Hits and Mechanisms

Discover our findings highlight the importance of 3D cell models in drug discovery. Download the poster!

Scientific publications | Oncodesign Services
Scientific resource
30/01/2024

Doublet and Triplet Combinations of Eribulin, Fulvestrant, and Palbociclib in Preclinical Breast Cancer Models

This study investigated in vivosynergism between eribulin and palbociclib in a breastcancer patient-derived xenograft (PDX) model.

Oncodesign Services Acquires ZoBio
Press release
23/01/2024

Oncodesign Services Acquires ZoBio

Acquisition of ZoBio, a Dutch CRO expert in biophysics-based small molecule drug discovery, by Oncodesign Services.

News
05/12/2023

Oncolytic Virus Research

Oncodesign Services has been working with ViraTherapeutics GmbH, an Austrian company and subsidiary of Boehringer Ingelheim, on their oncolytic viral immunotherapy since 2018.

Blog
01/12/2023

How to repurpose your cancer drug to a Molecular RadioTherapy drug candidate

In this blog, Dr Eftychia Koumarianou deals with the ground-breaking and intriguing approach that hides behind the theranostics.

Medicinal chemistry department | Oncodesign Services
News
31/10/2023

Navigating from molecules to medicines in our chemistry department

Christophe Parsy, Ph.D, MBA, head of the medicinal chemistry team since 2020, presents his team's daily challenges and missions.

Scientific publication
24/10/2023

Relier l’inflammation et la complexité du cancer

Dans cette publication, Olivier Duchamp souligne qu'une meilleure compréhension et modélisation du processus d'inflammation chronique pourrait aider à développer de nouvelles stratégies anti-inflammatoires pour la prévention et le traitement du cancer.

Octobre Rose - Oncodesign Services
News
19/10/2023

Breast cancer awareness month

To progress through new treatments, Oncodesign Services supports since many years pharmaceutical companies with breast cancer models such as PDX and CDX models.